News of Note—Commercial production of Portola's Andexxa underway

Woman typing on computer
Here's more about pharma manufacturing. (Max Pixel/CC0)

> Lonza has begun commercial production in Spain of Portola’s second-generation Andexxa, a highly anticipated bleeding antidote for some anticoagulants. Release

> Indian biotech Enzene Biosciences has teamed up with Novasep for a purification installation for its plant in Pune, India, which will allow it to do end-to-end continuous manufacturing of a mAb. Release

> The FDA has gotten a federal court to prevent Ranier’s Compounding Laboratory in Jeanette, Pennsylvania, from making and selling compounded drugs on grounds that it has sold sterile injectables that failed to meet standards. Release


Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This on-demand webinar discusses the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.